These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32805056)

  • 1. The Positive Association of Plasma Myristic Acid and Apolipoprotein CIII Concentrations.
    Fernandez ML
    J Nutr; 2020 Oct; 150(10):2613-2614. PubMed ID: 32805056
    [No Abstract]   [Full Text] [Related]  

  • 2. The Positive Association between Plasma Myristic Acid and ApoCIII Concentrations in Cardiovascular Disease Patients Is Supported by the Effects of Myristic Acid in HepG2 Cells.
    Olivieri O; Speziali G; Castagna A; Pattini P; Udali S; Pizzolo F; Liesinger L; Gindlhuber J; Tomin T; Schittmayer M; Birner-Gruenberger R; Cecconi D; Girelli D; Friso S; Martinelli N
    J Nutr; 2020 Oct; 150(10):2707-2715. PubMed ID: 32710763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of antisense oligonucleotide therapy against apolipoprotein-CIII in hypertriglyceridemia.
    Gouni-Berthold I
    Atheroscler Suppl; 2017 Nov; 30():19-27. PubMed ID: 29096837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein CIII bound to apoB-containing lipoproteins is associated with small, dense LDL independent of plasma triglyceride levels in healthy men.
    Shin MJ; Krauss RM
    Atherosclerosis; 2010 Jul; 211(1):337-41. PubMed ID: 20303494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteins.
    Mendivil CO; Zheng C; Furtado J; Lel J; Sacks FM
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):239-45. PubMed ID: 19910636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertriglyceridemia Associated With Abdominal Obesity: Getting Contributing Factors Into Perspective.
    Carpentier AC
    Arterioscler Thromb Vasc Biol; 2015 Oct; 35(10):2076-8. PubMed ID: 26399918
    [No Abstract]   [Full Text] [Related]  

  • 7. Apolipoprotein CIII: 42 years old and even more interesting.
    Ginsberg HN; Brown WV
    Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):471-3. PubMed ID: 21325666
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of omega-3 supplements on plasma apolipoprotein C-III concentrations: a systematic review and meta-analysis of randomized controlled trials.
    Sahebkar A; Simental-Mendía LE; Mikhailidis DP; Pirro M; Banach M; Sirtori CR; Reiner Ž
    Ann Med; 2018 Nov; 50(7):565-575. PubMed ID: 30102092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma apolipoprotein CI and CIII levels are associated with increased plasma triglyceride levels and decreased fat mass in men with the metabolic syndrome.
    van der Ham RL; Alizadeh Dehnavi R; Berbée JF; Putter H; de Roos A; Romijn JA; Rensen PC; Tamsma JT
    Diabetes Care; 2009 Jan; 32(1):184-6. PubMed ID: 18835943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to a urate-lowering diet according to polymorphisms in the apolipoprotein AI-CIII-AIV cluster.
    Cardona F; Tinahones FJ; Collantes E; Garcia-Fuentes E; Escudero A; Soriguer F
    J Rheumatol; 2005 May; 32(5):903-5. PubMed ID: 15868628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein CIII predicts cardiovascular events in patients with coronary artery disease: a prospective observational study.
    Katzmann JL; Werner CM; Stojakovic T; März W; Scharnagl H; Laufs U
    Lipids Health Dis; 2020 May; 19(1):116. PubMed ID: 32473635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Not Just Arterial Damage: Increased Incidence of Venous Thromboembolic Events in Cardiovascular Patients With Elevated Plasma Levels of Apolipoprotein CIII.
    Olivieri O; Turcato G; Moruzzi S; Castagna A; Girelli D; Pizzolo F; Friso S; Sandri M; Bassi A; Martinelli N
    J Am Heart Assoc; 2019 Jan; 8(2):e010973. PubMed ID: 30646800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of apolipoprotein-CIII (apoC-III), endothelium-dependent vasodilation and peripheral neuropathy in a multi-ethnic population with type 2 diabetes.
    Pek SLT; Sum CF; Yeoh LY; Lee SBM; Tang WE; Lim SC; Tavintharan S
    Metabolism; 2017 Jul; 72():75-82. PubMed ID: 28641786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease.
    Ooi EM; Chan DT; Watts GF; Chan DC; Ng TW; Dogra GK; Irish AB; Barrett PH
    J Lipid Res; 2011 Apr; 52(4):794-800. PubMed ID: 21297177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New regulatory and signal functions for myristic acid].
    Beauchamp E; Rioux V; Legrand P
    Med Sci (Paris); 2009 Jan; 25(1):57-63. PubMed ID: 19154695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of statin therapy on plasma apolipoprotein CIII concentrations: A systematic review and meta-analysis of randomized controlled trials.
    Sahebkar A; Simental-Mendía LE; Mikhailidis DP; Pirro M; Banach M; Sirtori CR; Ruscica M; Reiner Ž
    J Clin Lipidol; 2018; 12(3):801-809. PubMed ID: 29580713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor II activity is similarly increased in patients with elevated apolipoprotein CIII and in carriers of the factor II 20210A allele.
    Olivieri O; Martinelli N; Baroni M; Branchini A; Girelli D; Friso S; Pizzolo F; Bernardi F
    J Am Heart Assoc; 2013 Nov; 2(6):e000440. PubMed ID: 24242684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human apolipoprotein CIII levels; evaluation of three assay methods.
    Sandin Å; Olofsson C; Strålfors A; Rajamand Ekberg N; Brismar K; Juntti-Berggren L; Eggertsen G
    Scand J Clin Lab Invest; 2020 May; 80(3):230-235. PubMed ID: 32108506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of cardiovascular events with increased apolipoprotein CIII: A systematic review and meta-analysis.
    Wyler von Ballmoos MC; Haring B; Sacks FM
    J Clin Lipidol; 2015; 9(4):498-510. PubMed ID: 26228667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of plasma apolipoprotein C-III as a determinant of diet-induced changes in plasma triglyceride levels.
    Desroches S; Ruel IL; Deshaies Y; Paradis ME; Archer WR; Couture P; Bergeron N; Lamarche B
    Eur J Clin Nutr; 2008 Jan; 62(1):10-7. PubMed ID: 17299465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.